compounded retatrutide vs tirzepatide for weight loss Retatrutide Peptide Therapy | California

These included: Nausea (the most frequently reported adverse effect) Vomiting Diarrhoea Constipation Decreased appetite These effects were generally dose-dependent, occurring more frequently and with greater severity at higher doses

Estrogen Imbalance: Too much or too little estrogen (common in perimenopause or menopause) can steer fat to your midsection

A total of 92% of participants achieved at least 5% weight loss, while 83% achieved reductions of 15% in body weight

Clinical data shows an average regain of 5.63 kilograms after stopping semaglutide, with most patients returning to near-baseline weight by 18 months post-discontinuation

Not all patients respond the same way to retatrutide

If a plan covers a branded product, your share may differ substantially